DexCom Reports Q3 Revenue of $1.344B, Raises 2026 Outlook, Authorizes $1B Buyback

DexCom reported Q3 2026 revenue of $1.344B, up 11% year over year, with GAAP gross margin of 64.3% and operating margin of 24.3%. It raised full-year 2026 revenue and operating margin guidance and authorized a share repurchase of up to $1.0B.